Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
340B Health
Providers
J&J gives up controversial 340B rebate plan
The drugmaker told HRSA Monday it has "no choice" but to forego a requirement for DSH covered entities to obtain their drug discounts via rebate.
Dave Muoio
Sep 30, 2024 3:10pm
New House 340B bill a pharma industry 'wish list,' hospitals say
May 29, 2024 1:30pm
HHS streamlines 340B dispute process to hospitals' delight
Apr 19, 2024 4:30pm
Appeals court affirms Ark. law against drugmakers' 340B limits
Mar 13, 2024 4:35pm
'Stunning' 340B court ruling calls HRSA authority into question
Nov 7, 2023 4:30pm
Consolidation may help some providers stay afloat, experts say
Jun 9, 2023 7:15am